PEGylated MGF
moderate riskAlso: Mechano Growth Factor · PEG-MGF · IGF-1Ec splice variant
Mechano Growth Factor (MGF) is a splice variant of IGF-1 produced locally in response to mechanical stress (exercise). PEGylation extends its short half-life. Acts on satellite (muscle stem) cells, distinct from the systemic IGF-1 receptor axis.
Reported Benefits
Satellite cell activation / muscle repair
Animal models show significant satellite cell proliferation and accelerated muscle repair post-injury.
Mechanism of Action
Unique E-domain peptide acts on a distinct receptor from IGF-1R (not fully characterized); activates muscle satellite cells; promotes myoblast proliferation and differentiation; PEGylation extends half-life to ~3 days.
The Satellite Cell Mechanism
MGF’s appeal lies in its specific targeting of muscle satellite cells — the stem cells responsible for muscle hypertrophy and repair. This mechanism is distinct from and potentially additive to the systemic IGF-1 axis, making it of interest for sports medicine applications.
Human data is essentially absent beyond theoretical extrapolation from animal models.
✦ Sponsored
Stop Guessing About Your Health. Start Optimizing It.
Advanced diagnostics and licensed medical providers delivering personalized longevity care to uncover root causes, optimize health, and track progress virtually or in person.
Learn More →
Regulatory Status
Research OnlySafety Profile
Side Effects
- •WADA-prohibited
- •Limited safety data
- •Potential immune response to PEG
Contraindications
- •Active malignancy
Drug Interactions
- •Insulin
- •IGF-1 preparations
Primary Uses
Used For
Planning a protocol?
Use the AI Stack Builder to generate a phased schedule, compatibility analysis, and monitoring checklist.
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe PEGylated MGF?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →